StockNews.com started coverage on shares of Atossa Therapeutics (NASDAQ:ATOS – Get Rating) in a research note released on Thursday morning. The brokerage issued a sell rating on the stock. Atossa Therapeutics Trading Up 2.0 % ATOS opened at $0.73 on Thursday. The company’s 50 day moving average is $0.69 and its 200 day moving average […]
Press Release Evolution of the Atos Board of Directors and convening of the 2023 Annual General Meeting Further strengthening the diversity of skills within the Board of Directors to support the
Paris, France - May 16, 2023 - Eviden, an Atos business, ColibrITD and ONERA today announce the launch of VulQain, a research project, funded by the French Defense Innovation Agency, to build the
16.05.2023 - Press Release Eviden launches ElevateNow to drive customer innovation on their SAP transformation journey Paris, France – May 16, 2023 – Eviden, the Atos business leading in digital, cloud, big data and security, today announces “ElevateNow”, and . Seite 1
Press Release Eviden launches ElevateNow to drive customer innovation on their SAP transformation journey Paris, France - May 16, 2023 - Eviden, the Atos business leading in digital